Utility of Intravenous Curcumin Nanodelivery Systems for Improving <i>In Vivo</i> Pharmacokinetics and Anticancer Pharmacodynamics
Mahsa Bagheri(Witten/Herdecke University), Michal Heger(Utrecht University), Robbert J. Kok(Utrecht University), Wim E. Hennink(Utrecht University), Cornelus F. van Nostrum(Utrecht University), Gert Storm(Yong In University)
Cited by 27
Related Papers
Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
|Frontiers in Pharmacology|2018|937
Sheddable Coatings for Long-Circulating Nanoparticles
|Pharmaceutical Research|2007|549
RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature
|Drug Resistance Updates|2005|461
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
|Advanced Drug Delivery Reviews|2013|396
Diverse origins of the myofibroblast—implications for kidney fibrosis
|Nature Reviews Nephrology|2015|305